Dr. Jessica A. Thomes Pepin
Claim this profileAbbott-Northwestern Hospital
Studies Adenocarcinoma
Studies Endometrioid Carcinoma
10 reported clinical trials
26 drugs studied
Area of expertise
1Adenocarcinoma
Stage IV
Stage III
Stage II
2Endometrioid Carcinoma
Stage IV
Stage II
MMR negative
Affiliated Hospitals
Clinical Trials Jessica A. Thomes Pepin is currently running
Ipatasertib + Megestrol Acetate
for Endometrial Cancer
This trial is testing if combining two drugs, ipatasertib and megestrol acetate, is more effective than using megestrol acetate alone for treating women with endometrial cancer that has returned or spread. Ipatasertib blocks enzymes needed for cancer cell growth, while megestrol acetate reduces and blocks estrogen, which some cancer cells need to grow.
Recruiting1 award Phase 1 & 2
Letrozole +/- Chemotherapy
for Ovarian Cancer
This phase III trial studies how well letrozole with or without paclitaxel and carboplatin works in treating patients with stage II-IV low-grade serous carcinoma of the ovary, fallopian tube, or peritoneum. Letrozole is an enzyme inhibitor that lowers the amount of estrogen made by the body which in turn may stop the growth of tumor cells that need estrogen to grow. Drugs used in chemotherapy, such as paclitaxel and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether giving letrozole alone or in combination with paclitaxel and carboplatin works better in treating patients with low-grade serous carcinoma of the ovary, fallopian tube, or peritoneum compared to paclitaxel and carboplatin without letrozole.
Recruiting2 awards Phase 318 criteria
More about Jessica A. Thomes Pepin
Clinical Trial Related1 year of experience running clinical trials · Led 10 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Jessica A. Thomes Pepin has experience with
- Olaparib
- Cediranib Maleate
- Durvalumab
- Behavioral Dietary Intervention
- Compliance Monitoring
- Exercise Intervention
Breakdown of trials Jessica A. Thomes Pepin has run
Adenocarcinoma
Endometrioid Carcinoma
Ovarian Cancer
Serous Cystadenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jessica A. Thomes Pepin specialize in?
Jessica A. Thomes Pepin focuses on Adenocarcinoma and Endometrioid Carcinoma. In particular, much of their work with Adenocarcinoma has involved Stage IV patients, or patients who are Stage III.
Is Jessica A. Thomes Pepin currently recruiting for clinical trials?
Yes, Jessica A. Thomes Pepin is currently recruiting for 4 clinical trials in Minneapolis Minnesota. If you're interested in participating, you should apply.
Are there any treatments that Jessica A. Thomes Pepin has studied deeply?
Yes, Jessica A. Thomes Pepin has studied treatments such as Olaparib, Cediranib Maleate, Durvalumab.
What is the best way to schedule an appointment with Jessica A. Thomes Pepin?
Apply for one of the trials that Jessica A. Thomes Pepin is conducting.
What is the office address of Jessica A. Thomes Pepin?
The office of Jessica A. Thomes Pepin is located at: Abbott-Northwestern Hospital, Minneapolis, Minnesota 55407 United States. This is the address for their practice at the Abbott-Northwestern Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.